CPIC: Clinical Pharmacogenetics Implemen... [Clin Pharmacol Ther. 2011] - PubMed

loading

Pharmacogenomics: "noninferiority" is sufficient for initial implementation. [Clin Pharmacol Ther. 2011]
Pharmacogenomics: "noninferiority" is sufficient for initial implementation.
Altman RB. Clin Pharmacol Ther. 2011 Mar; 89(3):348-50.
Review The 1200 patients project: creating a new medical model system for clinical implementation of pharmacogenomics. [Clin Pharmacol Ther. 2012]
Review The 1200 patients project: creating a new medical model system for clinical implementation of pharmacogenomics.
O'Donnell PH, Bush A, Spitz J, Danahey K, Saner D, Das S, Cox NJ, Ratain MJ. Clin Pharmacol Ther. 2012 Oct; 92(4):446-9. Epub 2012 Aug 29.
Review Pharmacogenetic testing: time for clinical practice guidelines. [Clin Pharmacol Ther. 2011]
Review Pharmacogenetic testing: time for clinical practice guidelines.
Amstutz U, Carleton BC. Clin Pharmacol Ther. 2011 Jun; 89(6):924-7. Epub 2011 Apr 20.
Pharmacogenomics and individualized medicine: translating science into practice. [Clin Pharmacol Ther. 2012]
Pharmacogenomics and individualized medicine: translating science into practice.
Crews KR, Hicks JK, Pui CH, Relling MV, Evans WE. Clin Pharmacol Ther. 2012 Oct; 92(4):467-75. Epub 2012 Sep 5.
Review Pharmacogenomics: bridging the gap between science and practice. [J Am Pharm Assoc (2003). 2010]
Review Pharmacogenomics: bridging the gap between science and practice.
Lee KC, Ma JD, Kuo GM. J Am Pharm Assoc (2003). 2010 Jan-Feb; 50(1):e1-14; quiz e15-7.

Clinical pharmacogenetics implementation consortium guidelines for thiopurine methyltransferase genotype and thiopurine dosing: 2013 update. [Clin Pharmacol Ther. 2013]
Clinical pharmacogenetics implementation consortium guidelines for thiopurine methyltransferase genotype and thiopurine dosing: 2013 update.
Relling MV, Gardner EE, Sandborn WJ, Schmiegelow K, Pui CH, Yee SW, Stein CM, Carrillo M, Evans WE, Hicks JK, et al. Clin Pharmacol Ther. 2013 Apr; 93(4):324-5. Epub 2013 Jan 17.
Multilocus genotypes of relevance for drug metabolizing enzymes and therapy with thiopurines in patients with acute lymphoblastic leukemia. [Front Genet. 2012]
Multilocus genotypes of relevance for drug metabolizing enzymes and therapy with thiopurines in patients with acute lymphoblastic leukemia.
Stocco G, Franca R, Verzegnassi F, Londero M, Rabusin M, Decorti G. Front Genet. 2012; 3:309. Epub 2013 Jan 7.
Toward a clinical practice guide in pharmacogenomics testing for functional polymorphisms of drug-metabolizing enzymes. Gene/drug pairs and barriers perceived in Spain. [Front Genet. 2012]
Toward a clinical practice guide in pharmacogenomics testing for functional polymorphisms of drug-metabolizing enzymes. Gene/drug pairs and barriers perceived in Spain.
Agúndez JA, Abad-Santos F, Aldea A, Alonso-Navarro H, Bernal ML, Borobia AM, Borrás E, Carballo M, Carvajal A, García-Muñiz JD, et al. Front Genet. 2012; 3:273. Epub 2012 Nov 26.

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
References for this PMC Article
Citation referenced in PubMed article. Only valid for PubMed citations that are also in PMC.
Free in PMC
Free full text articles in PMC
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

CPIC: Clinical Pharmacogenetics Implementation Consortium of the Pharmacogenomic...
CPIC: Clinical Pharmacogenetics Implementation Consortium of the Pharmacogenomics Research Network.
Clin Pharmacol Ther. 2011 Mar ;89(3):464-7. doi: 10.1038/clpt.2010.279. Epub 2011 Jan 26 .

PubMed

Your browsing activity is empty.

Activity recording is turned off.

PubMed